- Home
- OCSL vs XERS Comparison
OCSL vs XERS Comparison
Compare OCSL & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OCSL | XERS |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2008 | 2018 |
Fundamental Metrics
Financial Performance| Metric | OCSL | XERS |
|---|---|---|
| Price | $12.87 | $7.11 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $14.33 | $10.43 |
| AVG Volume (30 Days) | 738.7K | ★ 1.9M |
| Earning Date | 02-03-2026 | 11-06-2025 |
| Dividend Yield | ★ 12.39% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $316,801,000.00 | $266,137,000.00 |
| Revenue This Year | N/A | $44.37 |
| Revenue Next Year | N/A | $27.87 |
| P/E Ratio | $32.76 | ★ N/A |
| Revenue Growth | N/A | ★ 42.05 |
| 52 Week Low | $12.44 | $3.14 |
| 52 Week High | $16.29 | $10.08 |
Technical Indicators
Market Signals| Indicator | OCSL | XERS |
|---|---|---|
| Relative Strength Index (RSI) | 32.15 | 45.49 |
| Support Level | $13.53 | $6.95 |
| Resistance Level | $12.99 | $7.26 |
| Average True Range (ATR) | 0.20 | 0.30 |
| MACD | -0.10 | 0.08 |
| Stochastic Oscillator | 12.02 | 69.88 |
Price Performance
Historical ComparisonAbout OCSL Oaktree Specialty Lending Corporation
Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).